• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>PIMCO Municipal Income II

PIMCO Municipal Income II

PIMCO Municipal Income II PML 3 Star

Last Price$11.81Day Change (%)0.17%
Open Price$11.81Day Change ($)0.02
Day Range11.81–11.8152-Week Range10.33–12.30

As of Thu 12/18/2014 09:31 AM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Fitch Affirms Progressive's Ratings Following ARX Controlling Interest Acquisition

    Fitch Affirms Progressive's Ratings Following ARX Controlling Interest Acquisition

  2. Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting

    Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting

  3. Seattle Genetics Highlights Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations in Frontline and Salvage Hodgkin Lymphoma at ASH Annual Meeting

    Seattle Genetics Highlights Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations in Frontline and Salvage Hodgkin Lymphoma at ASH Annual Meeting

  4. Fitch Affirms Montpelier's Ratings; Outlook Revised to Negative

    Fitch Affirms Montpelier's Ratings; Outlook Revised to Negative

  5. Year in Review: Municipal CEFs

    We take a look at 2012's municipal CEF performance, distribution cuts, mergers, and more.

  6. A Closer Look at CEF Duration Risk

    An examination of 10 CEFs with the highest duration risk.

  7. Genentech to Present Clinical Data from Six Different Medicines at American Society of Hematology (ASH) Annual Meeting

    Genentech to Present Clinical Data from Six Different Medicines at American Society of Hematology (ASH) Annual Meeting

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.